BLS vs PAR

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BLS

BLSPHARMA FPO [BLS]

56MEDIUM

PAR

PARA BIO FPO [PAR]

53MEDIUM

Score Breakdown

BLS PAR
Technical
49
65
Catalyst
55
51
Sentiment
50
50
Fundamental
96
60
Momentum
84
45
Risk Gate
50
50

Key Metrics

BLS Metric PAR
$193.2MMarket Cap$104.0M
218KAvg Volume (20d)1.6M
+0.0%Short InterestN/A
$1.10052-Week High$0.470
$0.33052-Week Low$0.135
+1.8%Daily Change+6.1%
$0.855Reference Price$0.175
+66.1%ROE-180.2%
+18.7%Profit MarginN/A

Active Signals

BLS Signals

●MACD momentum is losing steam
●Drifting lower — down 8.1% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (4.0x)
●Strong revenue growth (+150%)
●Piotroski F-Score strong (8/9, low-confidence approx)

PAR Signals

●MACD just crossed bullish — momentum is shifting to the upside
●Trading above both moving averages — the trend is your friend here
●Beating the Small Ords index — relative strength of 1.14, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Very high P/S ratio (12307.6x)
●Strong revenue growth (+51%)
●EPS estimates revised upward (+6pts)

Ask Scout AI to compare BLS and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs PCK →BLS vs PIQ →BLS vs RHY →BLS vs VIT →BMT vs ECS →
BLS Full Analysis → PAR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).